Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Efficacy of 23mg Versus 10mg of Donepezil in ParkInson's Disease With Dementia

NCT02415062 is registered in ClinicalTrials.gov with Inje University as lead sponsor.

NCT NCT02415062
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02415062 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Efficacy of 23mg Versus 10mg of Donepezil in ParkInson's Disease With Dementia
Lead sponsor
Inje University
Phase
Phase 2
Overall status
Unknown status
Start date
July 31, 2015
Completion date
December 31, 2017
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson's disease